Fieke Hoff

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Abhimanyu Garg

UNITED STATES

View details

Todd Alonzo

Professor

University of Southern California

UNITED STATES

View details

Tara Lin

University of Kansas Medical Center

UNITED STATES

View details

Steven Kornblau

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Terzah Horton

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Yazan F. Madanat

UNITED STATES

View details

Boaz Nachmias

ISRAEL

View details

Razqallah Hakem

Full Professor

University of Toronto

CANADA

View details

S. Vincent Rajkumar

Professor of Medicine

Mayo Clinic Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fieke Hoff

Research Interests

Explore related searches

Contact this professor

Articles (15)

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Beat-AML 2024 ELN-Refined Risk Stratification for Older Adults with Newly Diagnosed AML Given Lower-Intensity Therapy

A Novel Subtype of Acquired Generalized Lipodystrophy Associated With Subcutaneous Panniculitis-Like T-cell Lymphoma

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial

Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group

Real-world outcomes of frontline venetoclax-based therapy in older adults with acute myeloid leukemia: an analysis utilizing EHR data

DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children’s Oncology Group

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance

Early‐onset diabetes mellitus as a presenting feature of Werner's syndrome in an Indian family

The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant

AML-522 Outcomes of Patients Treated With Venetoclax-Based Combination Therapy in Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms; Real World Data from a Single Center Cohort

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia

Collaborators (9)

Abhimanyu Garg

Todd Alonzo

Tara Lin

Steven Kornblau

Terzah Horton

Yazan F. Madanat

Boaz Nachmias

Razqallah Hakem

S. Vincent Rajkumar

Make your next move.